• Launched targeted, blood-based GeneStrat genomic panel growing to 600+ tests/month in 2017• Relaunched VeriStrat test with new messaging and call point leading to 116% sales growth in 2016• Lead cross-functional product planning group to expand on-market products and manage product pipeline• Managed publication strategy resulting in generation of 8 manuscripts and 27 abstracts • Integral part of sales training program educating field on how core products (GeneStrat and VeriStrat) fit into the lung cancer treatment landscape

• Closed top DOD account in 2014 (Walter Reed Medical Center; ~$2.5M in annual revenue)• Partnered with Nanostring for strategic distribution of platform and Prosigna breast cancer assay• Product expert on client connectivity solutions resulting in significant uptake of virtual pathology platform• Worked with VP Marketing to help develop and evaluate new sales collateral

• Managed launch of new Barrett's Esophagus product including development of sales collateral, design of new reporting format, and sales team training• Lead re-launch of pancreatic cyst product with new messaging and market strategy and improved sales collateral• Coordinated corporate effort to overturn negative change to Medicare LCD leading to favorable amendment of coverage policy• Managed completion and publication of health economics study in cystic pancreatic disease• Lead initiative to update and improve product messaging for sales team• Developed new sales training program to accelerate increase in sales volume• Lead development and launch of the National Pancreatic Cyst Registry website to educate users on study results• Managed mail and email campaign to drive awareness of the National Pancreatic Cyst Registry• Managed completion and publication of health economics study in pancreatic disease• Manage sales territory that grew 250% in Q3 2012• Helped coordinate faster specimen accrual for Barrett's Esophagus clinical study

• #4/22 in sales volume nationally for 2011• #1 in Western Region for sales growth for 2011(500% year over year)• #1 in sales volume for Western Region for 2011• Recruited top oncology sender for 2011• Recruited first two academic KOL’s for nationwide speaker’s bureau• Organized first advisory board for gynecologic oncologists to prepare for launch of new endometrial cancer signature

• President’s Club winner for 2010• #1 in the Western Region in sales growth and volume for 2010 (6 sales reps). Ranked in the top 15% nationally (#9/60)• Increased sales volume 235% year over year in 2009, and 200% year over year in 2010• 1 out of 5 reps chosen nationally for STAR Advisory Board• Recruited the 1st KOL speaker in the West helping the region to achieve the largest sales growth in the nation in 2010• Leveraged key relationships to penetrate UCSF and recruit the gynecologic oncology team for commercial use of ChemoFx• Utilized clinical knowledge and sales expertise to penetrate Stanford health system establishing new business in gynecologic oncology and thoracic surgery• Enrolled 5 clinical trial sites to demonstrate assay effectiveness in management of multiple types of cancer. This accounts for 62% of the clinical trial sites in the Western Region

• Launched new marketing materials in 2008 leading to 320% year over year growth in national sales volume• Provided lab tours and technical product education for all thought leaders training to be Speakers• Attended trade shows and conferences throughout the country to develop relationships with key physicians and their institutions• Project leader for identification of target cancer indications for business development and clinical trials• Created FAQ book to assist sales field with clinical responses to common objections• Trained all sales classes on technical and clinical aspects of ChemoFx

• Managed lab staff growth from 4 to 22 employees• Developed organizational structure to maximize productivity by leveraging core competencies and using strategic scheduling methods• Improved success rate for reporting test results by 10% and decreased TAT by 5% while managing increased commercial specimen volume• Implemented laboratory automation system from initial generation of specifications to scientific validation of new robotic assay and subsequent transfer of system to CLIA regulated laboratory - led to 10% labor cost reduction and 20% consumables cost reduction• Effectively managed $1.5M annual operating budget to ensure adequate allocation for staffing, capex, and operating supplies• Redesigned clinical laboratory to allow for 700% increase in specimen volume. Project completed in 6 weeks for $175K allowing for monthly revenue growth from $500K to $3.5M• Managed multiple clinical trials to ensure quality testing, accurate data collection, adherence to GCP protocols, and company-wide visibility into patient accrual

• Managed information portal development on accelerated schedule through generation of software specifications, frequent feedback meetings with users, and aggressive timeline management. Resulted in timely release of software application encompassing all aspects of business process• Coordinated corporate HIPAA compliance project through review of external audit, creation of timeline, and allocation of tasks

• Coordinated retrospective clinical study of patients and devised data tracking method which led to on-time completion of study• Developed testing protocols and carried out experiments to update ChemoFx assay to a more robust and scalable version